Product Information
ISRADIPINE 5 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.6472 per EA under NDC 16252054001. Its NADAC has been published 404 times since Nov 28, 2013.
Strength
5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
16252054001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ISRADIPINEApproval Type
Generic (ANDA)
FDA Application
ANDA077317On Market Since
1/5/2006
Pharmacological Classes
Price Statistics
The NADAC for ISRADIPINE 5 MG CAPSULE has been published 404 times since Nov 28, 2013, and over the history we have for it it has risen 18.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6472 per EA |
|---|---|
| All-time high | $2.5423 (Feb 12, 2025) |
| All-time low | $1.2690 (Jul 19, 2017) |
| 52-week high | $2.4815 |
| 52-week low | $1.6114 |
| Median price | $1.4136 |
| Average price | $1.5923 |
| Largest weekly change | +58.8% (May 22, 2024) |
| Weeks tracked | 404 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ISRADIPINE 5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ISRADIPINE 5 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $1.6472 per EA (NDC 16252054001), effective Jun 24, 2026.
How has the price of ISRADIPINE 5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ISRADIPINE 5 MG CAPSULE has risen 18.1%. It has been tracked across 404 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ISRADIPINE 5 MG CAPSULE?
Since Nov 28, 2013, the NADAC for ISRADIPINE 5 MG CAPSULE has ranged from a low of $1.2690 (Jul 19, 2017) to a high of $2.5423 (Feb 12, 2025), with a median of $1.4136 per EA.
Are there cheaper alternatives to ISRADIPINE 5 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ISRADIPINE 5 MG CAPSULE, but none are currently priced below it.
Who manufactures ISRADIPINE 5 MG CAPSULE?
ISRADIPINE 5 MG CAPSULE (NDC 16252054001) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification